232 related articles for article (PubMed ID: 33311557)
21. NOX5 mediates the crosstalk between tumor cells and cancer-associated fibroblasts via regulating cytokine network.
Chen J; Wang Y; Zhang W; Zhao D; Zhang L; Zhang J; Fan J; Zhan Q
Clin Transl Med; 2021 Aug; 11(8):e472. PubMed ID: 34459125
[TBL] [Abstract][Full Text] [Related]
22. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.
Zhang Y; Zhang YL; Chen HM; Pu HW; Ma WJ; Li XM; Ma H; Chen X
World J Gastroenterol; 2014 May; 20(18):5533-9. PubMed ID: 24833884
[TBL] [Abstract][Full Text] [Related]
23. Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma.
Dunbar KJ; Karakasheva TA; Tang Q; Efe G; Lin EW; Harris M; Sahu V; Sachdeva UM; Hu J; Klein-Szanto AJ; Henick B; Diehl JA; Nakagawa H; Rustgi AK
Mol Cancer Res; 2023 Jul; 21(7):741-752. PubMed ID: 37027010
[TBL] [Abstract][Full Text] [Related]
24. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
[TBL] [Abstract][Full Text] [Related]
25. Periostin derived from cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression via ADAM17 activation.
Ishibashi Y; Mochizuki S; Horiuchi K; Tsujimoto H; Kouzu K; Kishi Y; Okada Y; Ueno H
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166669. PubMed ID: 36813090
[TBL] [Abstract][Full Text] [Related]
26. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
27. LAMC1 upregulation via TGFβ induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-κB-CXCL1-STAT3.
Fang L; Che Y; Zhang C; Huang J; Lei Y; Lu Z; Sun N; He J
Mol Oncol; 2021 Nov; 15(11):3125-3146. PubMed ID: 34218518
[TBL] [Abstract][Full Text] [Related]
28. S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways.
Tanigawa K; Tsukamoto S; Koma YI; Kitamura Y; Urakami S; Shimizu M; Fujikawa M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2022 Mar; 192(3):536-552. PubMed ID: 34954212
[TBL] [Abstract][Full Text] [Related]
29. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
30. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
[TBL] [Abstract][Full Text] [Related]
31. Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma.
Liu B; Zhang B; Qi J; Zhou H; Tan L; Huang J; Huang J; Fang X; Gong L; Luo J; Liu S; Fu L; Ling F; Ma S; Lai-Wan Kwong D; Wang X; Guan XY
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2307914120. PubMed ID: 37816055
[TBL] [Abstract][Full Text] [Related]
32. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
[TBL] [Abstract][Full Text] [Related]
33. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
[TBL] [Abstract][Full Text] [Related]
34. GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells.
Peng F; He Q; Cheng C; Pan J
Cell Biochem Funct; 2019 Jan; 37(1):42-51. PubMed ID: 30575058
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
[TBL] [Abstract][Full Text] [Related]
36. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
[TBL] [Abstract][Full Text] [Related]
37. Low expression of LncRNA-CAF attributed to the high expression of HIF1A in esophageal squamous cell carcinoma and gastric cancer patients.
Bahramian S; Sahebi R; Roohinejad Z; Delshad E; Javid N; Amini A; Razavi AE; Shafiee M; Shamsabadi FT
Mol Biol Rep; 2022 Feb; 49(2):895-905. PubMed ID: 35040008
[TBL] [Abstract][Full Text] [Related]
38. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
Du F; Guo T; Cao C
Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
Masuda T; Nakashima T; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
J Cell Mol Med; 2019 Apr; 23(4):2984-2994. PubMed ID: 30734495
[TBL] [Abstract][Full Text] [Related]
40. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
